A carregar...
Sunitinib rechallenge with dose escalation in progressive metastatic renal cell carcinoma: A case report and literature review
RATIONALE: We aimed to present a case of sunitinib rechallenge with dosage escalation after disease progression, hopefully, providing an optional approach to the personalized medication management of progressive metastatic renal cell carcinoma (mRCC). PATIENT CONCERNS: The patient was admitted to ho...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081141/ https://ncbi.nlm.nih.gov/pubmed/30075524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011565 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|